|
Maravai LifeSciences Holdings, Inc. (MRVI) DCF Valuation
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
Maravai LifeSciences Holdings, Inc. (MRVI) Bundle
Gain insight into your Maravai LifeSciences Holdings, Inc. (MRVI) valuation analysis using our advanced DCF Calculator! Preloaded with real (MRVI) data, this Excel template enables you to adjust forecasts and assumptions, allowing for precise calculation of Maravai LifeSciences’ intrinsic value.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 143.1 | 284.1 | 799.2 | 883.0 | 288.9 | 391.3 | 529.9 | 717.6 | 971.7 | 1,315.9 |
| Revenue Growth, % | 0 | 98.48 | 181.33 | 10.48 | -67.28 | 35.42 | 35.42 | 35.42 | 35.42 | 35.42 |
| EBITDA | 48.2 | 138.3 | 585.8 | 610.0 | 712.4 | 254.1 | 344.1 | 466.0 | 631.1 | 854.6 |
| EBITDA, % | 33.67 | 48.67 | 73.29 | 69.08 | 246.56 | 64.94 | 64.94 | 64.94 | 64.94 | 64.94 |
| Depreciation | 24.1 | 25.8 | 24.8 | 38.1 | 48.8 | 39.3 | 53.2 | 72.1 | 97.6 | 132.2 |
| Depreciation, % | 16.83 | 9.09 | 3.1 | 4.32 | 16.88 | 10.04 | 10.04 | 10.04 | 10.04 | 10.04 |
| EBIT | 24.1 | 112.4 | 561.0 | 571.9 | 663.6 | 228.0 | 308.8 | 418.2 | 566.3 | 766.9 |
| EBIT, % | 16.84 | 39.58 | 70.19 | 64.77 | 229.67 | 58.28 | 58.28 | 58.28 | 58.28 | 58.28 |
| Total Cash | 24.7 | 236.2 | 551.3 | 632.1 | 575.0 | 266.8 | 361.3 | 489.3 | 662.6 | 897.3 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 18.0 | 51.0 | 117.5 | 146.8 | 55.7 | 63.5 | 86.0 | 116.5 | 157.7 | 213.6 |
| Account Receivables, % | 12.6 | 17.96 | 14.7 | 16.63 | 19.28 | 16.23 | 16.23 | 16.23 | 16.23 | 16.23 |
| Inventories | 14.2 | 33.3 | 51.6 | 43.2 | 51.4 | 39.7 | 53.8 | 72.9 | 98.7 | 133.6 |
| Inventories, % | 9.92 | 11.72 | 6.45 | 4.89 | 17.79 | 10.15 | 10.15 | 10.15 | 10.15 | 10.15 |
| Accounts Payable | 7.5 | 3.0 | 8.2 | 6.0 | 10.7 | 9.1 | 12.4 | 16.8 | 22.7 | 30.8 |
| Accounts Payable, % | 5.22 | 1.05 | 1.02 | 0.67848 | 3.71 | 2.34 | 2.34 | 2.34 | 2.34 | 2.34 |
| Capital Expenditure | -17.1 | -25.4 | -14.9 | -17.1 | -65.6 | -37.1 | -50.2 | -68.0 | -92.1 | -124.8 |
| Capital Expenditure, % | -11.98 | -8.94 | -1.86 | -1.94 | -22.69 | -9.48 | -9.48 | -9.48 | -9.48 | -9.48 |
| Tax Rate, % | 119.27 | 119.27 | 119.27 | 119.27 | 119.27 | 119.27 | 119.27 | 119.27 | 119.27 | 119.27 |
| EBITAT | 21.4 | 105.8 | 496.0 | 508.8 | -127.9 | 164.3 | 222.6 | 301.4 | 408.1 | 552.7 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 3.6 | 49.7 | 426.3 | 506.8 | -57.1 | 168.8 | 192.2 | 260.3 | 352.5 | 477.3 |
| WACC, % | 5.98 | 6.16 | 5.96 | 5.98 | 2.93 | 5.4 | 5.4 | 5.4 | 5.4 | 5.4 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 1,207.9 | |||||||||
| Long Term Growth Rate, % | 1.00 | |||||||||
| Free cash flow (T + 1) | 482 | |||||||||
| Terminal Value | 10,949 | |||||||||
| Present Terminal Value | 8,416 | |||||||||
| Enterprise Value | 9,624 | |||||||||
| Net Debt | 36 | |||||||||
| Equity Value | 9,588 | |||||||||
| Diluted Shares Outstanding, MM | 132 | |||||||||
| Equity Value Per Share | 72.68 |
What You Will Get
- Real Maravai Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for Maravai LifeSciences Holdings, Inc. (MRVI).
- Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates tailored for MRVI.
- Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Maravai’s fair value.
- Versatile Excel Template: Designed for quick edits, scenario testing, and detailed projections specific to Maravai LifeSciences Holdings, Inc. (MRVI).
- Time-Saving and Accurate: Avoid building models from scratch while ensuring precision and flexibility for MRVI.
Key Features
- Comprehensive DCF Calculator: Offers detailed unlevered and levered DCF valuation models tailored for Maravai LifeSciences Holdings, Inc. (MRVI).
- WACC Calculator: Pre-configured Weighted Average Cost of Capital sheet with adjustable inputs specific to MRVI.
- Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates to fit Maravai's projections.
- Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios relevant to Maravai LifeSciences.
- Interactive Dashboard and Charts: Visual representations highlight essential valuation metrics for streamlined analysis.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered Maravai LifeSciences data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for Maravai’s intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose Maravai LifeSciences Holdings, Inc. (MRVI)?
- Save Time: Quickly access essential data without the hassle of complex calculations.
- Enhance Accuracy: Utilize dependable scientific data and methodologies to minimize errors in research and development.
- Fully Customizable: Adjust parameters to align with your specific scientific needs and forecasts.
- Easy to Understand: Intuitive visualizations and outputs facilitate straightforward interpretation of results.
- Endorsed by Professionals: Developed for industry experts who prioritize accuracy and efficiency.
Who Should Use This Product?
- Investors: Accurately assess Maravai LifeSciences' fair value before making investment choices.
- CFOs: Utilize a professional-grade DCF model for financial reporting and analysis related to (MRVI).
- Consultants: Easily customize the template for valuation reports tailored to clients in the life sciences sector.
- Entrepreneurs: Acquire knowledge on financial modeling techniques employed by leading biotech firms.
- Educators: Implement it as a teaching resource to illustrate valuation methodologies in the life sciences field.
What the Template Contains
- Pre-Filled DCF Model: Maravai LifeSciences Holdings, Inc. (MRVI)’s financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate Maravai’s profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.